Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Marco, Sbolli"'
Autor:
Carlo Lombardi, Giulia Peveri, Dario Cani, Federica Latta, Andrea Bonelli, Daniela Tomasoni, Marco Sbolli, Alice Ravera, Valentina Carubelli, Nicola Saccani, Claudia Specchia, Marco Metra
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2650-2661 (2020)
Abstract Aims Acute heart failure (AHF) leads to a drastic increase in mortality and rehospitalization. The aim of the study was to identify prognostic variables in a real‐life population of AHF patients admitted to the emergency department with ac
Externí odkaz:
https://doaj.org/article/3ccd5913d51c48f5b8870bcc2f53effd
Publikováno v:
ESC Heart Failure, Vol 7, Iss 2, Pp 381-399 (2020)
Abstract Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid‐range LVEF (HFmrEF) category was identified in an attempt to uncover specific char
Externí odkaz:
https://doaj.org/article/837d57d1b7f24ff187c0bac994410d04
Autor:
Pompilio Faggiano, Elisabetta Dinatolo, Antonella Moreo, Benedetta De Chiara, Marco Sbolli, Francesco Musca, Antonio Curnis, Oriana Belli, Cristina Giannattasio, Cesare Tomasi, Marco Metra, Gloria Santangelo
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 6, p 1520 (2022)
Background and aim. Thromboembolic events due to left atrial appendage (LAA) thrombosis are the main complication of non-valvular atrial fibrillation (NVAF). Although anticoagulants are effective in patients with NVAF, a minimal residual thromboembol
Externí odkaz:
https://doaj.org/article/aed521aab9f640208b66fba53bb34219
Autor:
Pompilio Faggiano, Marta Scodro, Marco Sbolli, Luca Branca, Dario Cani, Francesca Valentini, Carlotta Perego, Martino Provini
Publikováno v:
Monaldi Archives for Chest Disease, Vol 88, Iss 2 (2018)
Stroke is the second largest cause of European cardiovascular and total mortality, largely due to atherosclerotic carotid artery narrowing or thromboembolism consequent to internal carotid artery stenosis. Current therapeutic indications suggest life
Externí odkaz:
https://doaj.org/article/cce361f20141404990660465ba203b7a
Autor:
Marco Sbolli, Barry H. Greenberg, Marco Metra, Andrew Y. Lin, Javed Butler, Nicolò Dasseni, Elisabetta Dinatolo
Publikováno v:
JACC: Heart Failure. 9:243-253
Despite advances in medical and device therapy, patients with heart failure remain at high risk for morbidity and mortality. Experimental and clinical studies have shown an association between heart failure and a hypercoagulable state, and that patie
Publikováno v:
Monaldi Archives for Chest Disease, Vol 87, Iss 2 (2017)
The preoperative evaluation of patients candidates to noncardiac surgery requires a knowledge of factors related both to type of surgery and to features of the single patient, potentially responsible for perioperative cardiovascular complications , f
Externí odkaz:
https://doaj.org/article/04babe650a434233b4966c5acc15fde6
Autor:
Mitchell A. Psotka, Marco Sbolli, Claudia Specchia, Marco Metra, Lee-Jen Wei, Christopher M. O'Connor, Chiara Oriecuia, Mona Fiuzat, Zachary R. McCaw, Carlotta Perego, Giulia Peveri
Publikováno v:
JACC: Heart Failure. 8:973-983
This study sought to demonstrate the statistical and utilitarian properties of restricted mean survival time (RMST) and restricted mean time lost (RMTL) for assessing treatments for heart failure (HF) with reduced ejection fraction.Although the hazar
Autor:
Pompilio, Faggiano, Elisabetta, Dinatolo, Antonella, Moreo, Benedetta De Chiara, Marco, Sbolli, Francesco, Musca, Curnis, Antonio, Oriana, Belli, Cristina, Giannattasio, Cesare, Tumasi, Metra, Marco, Gloria, Santangelo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3662::9015a0b6a80e66e28ae2f79973c88faa
http://hdl.handle.net/11379/555463
http://hdl.handle.net/11379/555463
Autor:
Valentina Carubelli, Dario Cani, Alice Ravera, Carlo Lombardi, Marco Metra, Daniela Tomasoni, Marco Sbolli, Andrea Bonelli, Federica Latta, Giulia Peveri, Claudia Specchia, Nicola Saccani
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2650-2661 (2020)
Aims Acute heart failure (AHF) leads to a drastic increase in mortality and rehospitalization. The aim of the study was to identify prognostic variables in a real‐life population of AHF patients admitted to the emergency department with acute short
Autor:
Randall C. Starling, Federica Latta, Biykem Bozkurt, Marco Sbolli, Clyde W. Yancy, Lynne W. Stevenson, John J.V. McMurray, JoAnn Lindenfeld, Ellis F. Unger, Mona Fiuzat, William T. Abraham, Christopher M. O'Connor, Mary Norine Walsh, John R. Teerlink, Paul A. Heidenreich, Javed Butler, Norman Stockbridge, Eldrin F. Lewis, Scott D. Solomon, G. Michael Felker, Robert Temple, Naomi Lowy
Publikováno v:
JACC: Heart Failure. 8:429-440
Heart failure (HF) patients experience a high burden of symptoms and functional limitations, and morbidity and mortality remain high despite successful therapies. The majority of HF drugs in the United States are approved for reducing hospitalization